{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:26:55Z","timestamp":1792290415724,"version":"4.4.0"},"reference-count":257,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["(#310372)"],"award-info":[{"award-number":["(#310372)"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00298","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T23:37:44Z","timestamp":1519083464000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":169,"title":["The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders"],"prefix":"10.3389","volume":"9","author":[{"given":"Rob J. W.","family":"Arts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.smim.2016.05.004","article-title":"Immune memory in invertebrates","volume":"28","author":"Milutinovic","year":"2016","journal-title":"Semin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","article-title":"Natural killer cell memory","volume":"43","author":"O\u2019Sullivan","year":"2015","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.smim.2016.09.002","article-title":"Immunometabolic circuits in trained immunity","volume":"28","author":"Arts","year":"2016","journal-title":"Semin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/jcp.24054","article-title":"Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression","volume":"227","author":"Donohoe","year":"2012","journal-title":"J Cell Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cell.2016.09.034","article-title":"beta-Glucan reverses the epigenetic state of LPS-induced immunological tolerance","volume":"167","author":"Novakovic","year":"2016","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/imr.12379","article-title":"Mechanisms involved in triggering rheumatoid arthritis","volume":"269","author":"Catrina","year":"2016","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI78087","article-title":"T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity","volume":"125","author":"Moulton","year":"2015","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11892-017-0848-5","article-title":"T-cell metabolism as a target to control autoreactive T cells in beta-cell autoimmunity","volume":"17","author":"Bordignon","year":"2017","journal-title":"Curr Diab Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrrheum.2009.278","article-title":"Sensors of the innate immune system: their link to rheumatic diseases","volume":"6","author":"Theofilopoulos","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.autrev.2008.12.019","article-title":"The role of innate immune responses in autoimmune disease development","volume":"8","author":"Waldner","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/art.38624","article-title":"Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis","volume":"66","author":"Toh","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.4049\/jimmunol.166.8.4915","article-title":"IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro","volume":"166","author":"Horwood","year":"2001","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12016-015-8519-2","article-title":"Macrophage polarization and bone formation: a review","volume":"51","author":"Horwood","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.berh.2008.02.002","article-title":"Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials","volume":"22","author":"Gerlag","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.1780390116","article-title":"Synovial tissue macrophage populations and articular damage in rheumatoid arthritis","volume":"39","author":"Mulherin","year":"1996","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/art.24505","article-title":"The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases","volume":"60","author":"Hamilton","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/nrrheum.2016.206","article-title":"Rheumatoid arthritis: anti-TNF agents go head-to-head","volume":"13","author":"Onuora","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/1529-0131(200004)43:4<775::AID-ANR8>3.0.CO;2-7","article-title":"Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis","volume":"43","author":"Stuhlmuller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1002\/art.23907","article-title":"Reactivation of rheumatoid arthritis after pregnancy: increased phagocyte and recurring lymphocyte gene activity","volume":"58","author":"Haupl","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2249.1996.d01-820.x","article-title":"Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release","volume":"106","author":"Liote","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4155\/fmc.15.55","article-title":"The PI3K\/Akt\/PTEN\/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?","volume":"7","author":"Malemud","year":"2015","journal-title":"Future Med Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.27504","article-title":"Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis","volume":"62","author":"Cejka","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B40","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2119\/molmed.2015.00040","article-title":"Antiinflammatory activity of a novel folic acid targeted conjugate of the mTOR inhibitor everolimus","volume":"21","author":"Lu","year":"2015","journal-title":"Mol Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/art.22512","article-title":"Histone deacetylase\/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients","volume":"56","author":"Huber","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.molimm.2009.01.010","article-title":"Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis","volume":"47","author":"Maciejewska Rodrigues","year":"2009","journal-title":"Mol Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molimm.2017.01.009","article-title":"Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification","volume":"83","author":"Lin","year":"2017","journal-title":"Mol Immunol"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1038\/gene.2017.20","article-title":"Inflammatory genes TNFalpha and IL6 display no signs of increased H3K4me3 in circulating monocytes from untreated rheumatoid arthritis patients","author":"Messemaker","year":"2017","journal-title":"Genes Immun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","article-title":"Metabolic signatures of T-cells and macrophages in rheumatoid arthritis","volume":"46","author":"Weyand","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.20160061","article-title":"GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis","volume":"213","author":"Littlewood-Evans","year":"2016","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e97501","DOI":"10.1371\/journal.pone.0097501","article-title":"Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0157360","DOI":"10.1371\/journal.pone.0157360","article-title":"Rheumatoid arthritis disadvantages younger patients for cardiovascular diseases: a meta-analysis","volume":"11","author":"Fransen","year":"2016","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.smim.2016.04.004","article-title":"Long-term activation of the innate immune system in atherosclerosis","volume":"28","author":"Christ","year":"2016","journal-title":"Semin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/eji.201545497","article-title":"Innate immune memory: implications for host responses to damage-associated molecular patterns","volume":"46","author":"Crisan","year":"2016","journal-title":"Eur J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/ard.2010.139196","article-title":"Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade","volume":"70","author":"Heinhuis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.autrev.2008.07.028","article-title":"The role of innate immunity in the induction of autoimmunity","volume":"8","author":"Pisetsky","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12016-017-8606-7","article-title":"Myeloid populations in systemic autoimmune diseases","volume":"53","author":"Morell","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1534\/g3.116.027326","article-title":"Several critical cell types, tissues, and pathways are implicated in genome-wide association studies for systemic lupus erythematosus","volume":"6","author":"Liu","year":"2016","journal-title":"G3 (Bethesda)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.autrev.2007.01.017","article-title":"Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus","volume":"6","author":"Kavai","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1136\/ard.2010.138057","article-title":"The genetics of systemic lupus erythematosus and implications for targeted therapy","volume":"70","author":"Sestak","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/ard.59.4.283","article-title":"Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility","volume":"59","author":"Steinbach","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fimmu.2016.00512","article-title":"CD16+ Monocyte subset was enriched and functionally exacerbated in driving T-cell activation and B-cell response in systemic lupus erythematosus","volume":"7","author":"Zhu","year":"2016","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/ard.2009.108043","article-title":"Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis","volume":"69","author":"Lyons","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/BBI.S29470","article-title":"B-cell and monocyte contribution to systemic lupus erythematosus identified by cell-type-specific differential expression analysis in RNA-seq data","volume":"9","author":"Dozmorov","year":"2015","journal-title":"Bioinform Biol Insights"},{"key":"B62","doi-asserted-by":"publisher","first-page":"13886","DOI":"10.1038\/srep13886","article-title":"Non-Classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous","volume":"5","author":"Mukherjee","year":"2015","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jaci.2015.04.008","article-title":"Single-cell systems-level analysis of human toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus","volume":"136","author":"O\u2019Gorman","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e93846","DOI":"10.1371\/journal.pone.0093846","article-title":"The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/art.40166","article-title":"Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type I interferon upregulation of interferon regulatory factor 1","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"20651","DOI":"10.1038\/srep20651","article-title":"A pathogenic IFNalpha, BLyS and IL-17 axis in systemic lupus erythematosus patients","volume":"6","author":"Lopez","year":"2016","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","article-title":"Cause and consequences of the activated type I interferon system in SLE","volume":"94","author":"Eloranta","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B69","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B71","doi-asserted-by":"publisher","first-page":"582352","DOI":"10.1155\/2012\/582352","article-title":"Genetics of SLE: functional relevance for monocytes\/macrophages in disease","volume":"2012","author":"Byrne","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.gene.6364133","article-title":"Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases","volume":"5","author":"Camargo","year":"2004","journal-title":"Genes Immun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2006.12.008","article-title":"The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus","volume":"123","author":"Sullivan","year":"2007","journal-title":"Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/gene.2009.66","article-title":"Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes","volume":"11","author":"Zhang","year":"2010","journal-title":"Genes Immun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/15592294.2015.1009764","article-title":"Interferon regulatory factor 1 and histone H4 acetylation in systemic lupus erythematosus","volume":"10","author":"Leung","year":"2015","journal-title":"Epigenetics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"507475","DOI":"10.1155\/2010\/507475","article-title":"Cytokine-induced monocyte characteristics in SLE","volume":"2010","author":"Zhang","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2217\/epi.15.47","article-title":"Monocyte enhancers are highly altered in systemic lupus erythematosus","volume":"7","author":"Shi","year":"2015","journal-title":"Epigenomics"},{"key":"B78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13148-016-0179-4","article-title":"H3K4 tri-methylation breadth at transcription start sites impacts the transcriptome of systemic lupus erythematosus","volume":"8","author":"Zhang","year":"2016","journal-title":"Clin Epigenetics"},{"key":"B79","first-page":"158","article-title":"Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients","volume":"28","author":"Dai","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3109\/08916934.2013.834495","article-title":"Metabolic control of the epigenome in systemic lupus erythematosus","volume":"47","author":"Oaks","year":"2014","journal-title":"Autoimmunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/art.1780331109","article-title":"Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis","volume":"33","author":"Richardson","year":"1990","journal-title":"Arthritis Rheum"},{"key":"B82","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/1529-0131(200102)44:2<397::AID-ANR59>3.0.CO;2-N","article-title":"Decreased ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients","volume":"44","author":"Deng","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B83","doi-asserted-by":"publisher","first-page":"42525","DOI":"10.1074\/jbc.M112.425371","article-title":"cAMP-responsive element modulator alpha (CREMalpha) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE)","volume":"287","author":"Rauen","year":"2012","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaut.2011.09.006","article-title":"Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus","volume":"37","author":"Zhang","year":"2011","journal-title":"J Autoimmun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.4049\/jimmunol.178.11.6941","article-title":"p300 Protein acetyltransferase activity suppresses systemic lupus erythematosus-like autoimmune disease in mice","volume":"178","author":"Forster","year":"2007","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3109\/03009740902895750","article-title":"Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL\/lpr mice","volume":"38","author":"Hu","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e13351","DOI":"10.1371\/journal.pone.0013351","article-title":"Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus","volume":"5","author":"Nakou","year":"2010","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J Transl Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12950-015-0083-2","article-title":"Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets","volume":"12","author":"Carvalheiro","year":"2015","journal-title":"J Inflamm (Lond)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1002\/art.23073","article-title":"Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjogren\u2019s syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development","volume":"56","author":"Manoussakis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B96","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/1744666X.2014.900441","article-title":"Macrophages: important players in primary Sjogren\u2019s syndrome?","volume":"10","author":"Zhou","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ajpath.2012.05.014","article-title":"Critical involvement of macrophage infiltration in the development of Sjogren\u2019s syndrome-associated dry eye","volume":"181","author":"Zhou","year":"2012","journal-title":"Am J Pathol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/cei.12378","article-title":"Monocytes from Sjogren\u2019s syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis","volume":"177","author":"Hauk","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B99","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/15027732.1986.12461396","article-title":"Blood mononuclear cells in patients with primary Sjogren\u2019s syndrome: production of interleukins, enumeration of interleukin-2 receptors, and DNA synthesis","volume":"61","author":"Enk","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"B100","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1186\/ar4294","article-title":"In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjogren\u2019s syndrome","volume":"15","author":"Volchenkov","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B101","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sjogren\u2019s syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur J Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/ard.2006.060772","article-title":"Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production","volume":"66","author":"Lavie","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B104","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1186\/ar3493","article-title":"Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjogren\u2019s syndrome","volume":"13","author":"Yoshimoto","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B105","first-page":"729","article-title":"Sjogren\u2019s syndrome with myalgia is associated with subnormal secretion of cytokines by peripheral blood mononuclear cells","volume":"31","author":"Eriksson","year":"2004","journal-title":"J Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/PAT.0b013e3283580388","article-title":"Altered IkappaBalpha expression promotes NF-kappaB activation in monocytes from primary Sjogren\u2019s syndrome patients","volume":"44","author":"Lisi","year":"2012","journal-title":"Pathology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clim.2016.03.010","article-title":"Cytokine-induced STAT1 activation is increased in patients with primary Sjogren\u2019s syndrome","volume":"165","author":"Pertovaara","year":"2016","journal-title":"Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cei.12614","article-title":"STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjogren\u2019s syndrome","volume":"181","author":"Pertovaara","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.autrev.2010.05.011","article-title":"Epigenetics in autoimmune disorders: highlights of the 10th Sjogren\u2019s syndrome symposium","volume":"9","author":"Lu","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.2174\/138920112802273326","article-title":"Epigenetics and Sjogren\u2019s syndrome","volume":"13","author":"Le Dantec","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3899\/jrheum.131154","article-title":"MicroRNA profiling in Chinese patients with primary Sjogren syndrome reveals elevated miRNA-181a in peripheral blood mononuclear cells","volume":"41","author":"Peng","year":"2014","journal-title":"J Rheumatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/eji.201040757","article-title":"Altered miR-146a expression in Sjogren\u2019s syndrome and its functional role in innate immunity","volume":"41","author":"Pauley","year":"2011","journal-title":"Eur J Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.imlet.2011.09.006","article-title":"Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjogren\u2019s syndrome","volume":"141","author":"Zilahi","year":"2012","journal-title":"Immunol Lett"},{"key":"B114","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13075-016-0987-0","article-title":"Sjogren\u2019s syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFbeta signaling","volume":"18","author":"Williams","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2013.07.016","article-title":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren\u2019s syndrome","volume":"171","author":"Shah","year":"2013","journal-title":"J Control Release"},{"key":"B116","first-page":"1078","article-title":"Criteria for diagnosis of Behcet\u2019s disease. International study group for Behcet\u2019s disease","volume":"335","author":"Wechsler","year":"1990","journal-title":"Lancet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.jaad.2003.12.023","article-title":"Treatment of Behcet\u2019s disease with granulocyte and monocyte adsorption apheresis","volume":"51","author":"Kanekura","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s10067-006-0371-6","article-title":"LPS-stimulated production of TNF-alpha by peripheral blood monocytes in patients with Behcet\u2019s disease","volume":"26","author":"Slobodin","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/rheumatology\/35.5.424","article-title":"Monocyte activity in Behcet\u2019s disease","volume":"35","author":"Sahin","year":"1996","journal-title":"Br J Rheumatol"},{"key":"B120","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"B121","first-page":"1282","article-title":"[Enhanced production of in vitro tumor necrosis factor-alpha from monocytes in Behcet\u2019s disease]","volume":"96","author":"Nakamura","year":"1992","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"B122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/BOR.0000000000000234","article-title":"Genetics of Behcet\u2019s disease","volume":"28","author":"Morton","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/eji.201343353","article-title":"The purinergic P2x7 receptor is expressed on monocytes in Behcet\u2019s disease and is modulated by TNF-alpha","volume":"44","author":"Castrichini","year":"2014","journal-title":"Eur J Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10067-009-1261-5","article-title":"Neutrophil hyperchemotaxis in Behcet\u2019s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses","volume":"28","author":"Neves","year":"2009","journal-title":"Clin Rheumatol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/rheumatology\/ken109","article-title":"Effects of vitamin D on expression of toll-like receptors of monocytes from patients with Behcet\u2019s disease","volume":"47","author":"Do","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/cei.12655","article-title":"The exaggerated inflammatory response in Behcet\u2019s syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-gamma\/CXCL10 IP-10 pathway","volume":"181","author":"Ambrose","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/art.38409","article-title":"Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behcet\u2019s disease","volume":"66","author":"Hughes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B130","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"Kraling","year":"1995","journal-title":"Pathobiology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab Invest"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B135","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/ar4251","article-title":"Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop","volume":"15","author":"Masuda","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B136","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1136\/annrheumdis-2012-201400","article-title":"Prostaglandin I(2) analogues enhance already exuberant Th17\u2009cell responses in systemic sclerosis","volume":"71","author":"Truchetet","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B139","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","article-title":"Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B140","first-page":"291","article-title":"Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1","volume":"23","author":"Giacomelli","year":"1996","journal-title":"J Rheumatol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1164\/ajrccm.149.5.8173768","article-title":"Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement","volume":"149","author":"Crestani","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/ard.51.3.362","article-title":"Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung","volume":"51","author":"Deguchi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/art.1780330619","article-title":"Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma","volume":"33","author":"Umehara","year":"1990","journal-title":"Arthritis Rheum"},{"key":"B144","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/cs0750561","article-title":"Increased spontaneous production of interleukin-1 together with inhibitory activity in systemic sclerosis","volume":"75","author":"Westacott","year":"1988","journal-title":"Clin Sci (Lond)"},{"key":"B145","first-page":"930","article-title":"Changes in circulating monocytes in patients with progressive systemic sclerosis","volume":"14","author":"Andrews","year":"1987","journal-title":"J Rheumatol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/ar1614","article-title":"Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis","volume":"7","author":"Allanore","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B147","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1523-1747.1999.00476.x","article-title":"Monocytes of patients with systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion)","volume":"112","author":"Sambo","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/rheumatology\/40.10.1089","article-title":"Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte\/macrophage cells","volume":"40","author":"Allanore","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"B149","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B150","doi-asserted-by":"publisher","first-page":"175","DOI":"10.14670\/HH-28.175","article-title":"Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis","volume":"28","author":"Yamaguchi","year":"2013","journal-title":"Histol Histopathol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"147616","DOI":"10.1155\/2015\/147616","article-title":"Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis","volume":"2015","author":"Elisa","year":"2015","journal-title":"J Immunol Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","article-title":"Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors","volume":"72","author":"Ciechomska","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e33508","DOI":"10.1371\/journal.pone.0033508","article-title":"Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis","volume":"7","author":"Binai","year":"2012","journal-title":"PLoS One"},{"key":"B154","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1186\/ar3180","article-title":"Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3324\/haematol.12526","article-title":"CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis","volume":"93","author":"Campioni","year":"2008","journal-title":"Haematologica"},{"key":"B156","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0090-1229(92)90193-R","article-title":"Decreased monocyte-mediated angiogenesis in scleroderma","volume":"64","author":"Koch","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/ar3167","article-title":"The cytokine language of monocytes and macrophages in systemic sclerosis","volume":"12","author":"Christmann","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B158","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","article-title":"Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction","volume":"137","author":"Pechkovsky","year":"2010","journal-title":"Clin Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/rr87","article-title":"Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific","volume":"2","author":"Pantelidis","year":"2001","journal-title":"Respir Res"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/art.39602","article-title":"Histone Demethylation and toll-like receptor 8-dependent cross-talk in monocytes promotes transdifferentiation of fibroblasts in systemic sclerosis via Fra-2","volume":"68","author":"Ciechomska","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A","article-title":"Pathogenesis of ANCA-associated systemic vasculitis","volume":"190","author":"Harper","year":"2000","journal-title":"J Pathol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/ard.58.4.237","article-title":"Monocyte activation in patients with Wegener\u2019s granulomatosis","volume":"58","author":"Muller Kobold","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/ndt\/gfg216","article-title":"Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis","volume":"18","author":"Wikman","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B164","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1189\/jlb.0902442","article-title":"Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation","volume":"78","author":"Hattar","year":"2005","journal-title":"J Leukoc Biol"},{"key":"B165","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1681\/ASN.V1191639","article-title":"Upregulation of CD14 and CD18 on monocytes In vitro by antineutrophil cytoplasmic autoantibodies","volume":"11","author":"Nowack","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1746-1596-4-23","article-title":"PR3-ANCA in Wegener\u2019s granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1\/2","volume":"4","author":"Uehara","year":"2009","journal-title":"Diagn Pathol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1365-2249.2002.01801.x","article-title":"Elevated monocytic IL-12 and TNF-alpha production in Wegener\u2019s granulomatosis is normalized by cyclophosphamide and corticosteroid therapy","volume":"128","author":"Lamprecht","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/JCI119662","article-title":"Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors","volume":"100","author":"Ralston","year":"1997","journal-title":"J Clin Invest"},{"key":"B169","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","article-title":"Active Wegener\u2019s granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10","volume":"160","author":"Ludviksson","year":"1998","journal-title":"J Immunol"},{"key":"B170","first-page":"495","article-title":"Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes","volume":"126","author":"Casselman","year":"1995","journal-title":"J Lab Clin Med"},{"key":"B171","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13075-016-0994-1","article-title":"Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis","volume":"18","author":"Johansson","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B172","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/03009742.2014.894568","article-title":"Decreased tumour necrosis factor-alpha production by monocytes of granulomatosis with polyangiitis","volume":"43","author":"Park","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/eji.201344284","article-title":"Abnormalities in iNKT cells are associated with impaired ability of monocytes to produce IL-10 and suppress T-cell proliferation in sarcoidosis","volume":"44","author":"Crawshaw","year":"2014","journal-title":"Eur J Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1346-8138.2003.tb00424.x","article-title":"Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients","volume":"30","author":"Okamoto","year":"2003","journal-title":"J Dermatol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/BF00180437","article-title":"Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis","volume":"70","author":"Homolka","year":"1992","journal-title":"Clin Investig"},{"key":"B176","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10875-008-9225-0","article-title":"Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis","volume":"29","author":"Wiken","year":"2009","journal-title":"J Clin Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1378\/chest.102.4.1128","article-title":"Soluble interleukin 2 receptors in patients with sarcoidosis","volume":"102","author":"Ina","year":"1992","journal-title":"Possible origin.Chest"},{"key":"B178","first-page":"419","article-title":"Ultrastructural study of expression of adhesion molecules between blood monocytes and alveolar macrophages from patients with pulmonary sarcoidosis","volume":"33","author":"Thole","year":"2001","journal-title":"J Submicrosc Cytol Pathol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1378\/chest.106.1.156","article-title":"Significance of interleukin 6 in patients with sarcoidosis","volume":"106","author":"Sahashi","year":"1994","journal-title":"Chest"},{"key":"B180","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000236532","article-title":"Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis","volume":"102","author":"Terao","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2249.2011.04456.x","article-title":"In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis","volume":"166","author":"Tercelj","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/BF01727514","article-title":"Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence","volume":"66","author":"Barth","year":"1988","journal-title":"Klin Wochenschr"},{"key":"B183","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.humimm.2012.05.005","article-title":"Changed phagocytic activity and pattern of Fcgamma and complement receptors on blood monocytes in sarcoidosis","volume":"73","author":"Dubaniewicz","year":"2012","journal-title":"Hum Immunol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1378\/chest.08-0443","article-title":"Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis","volume":"134","author":"Heron","year":"2008","journal-title":"Chest"},{"key":"B185","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2249.2001.01655.x","article-title":"Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells","volume":"126","author":"Mizuno","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B186","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.4049\/jimmunol.154.4.1879","article-title":"Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation","volume":"154","author":"Perez","year":"1995","journal-title":"J Immunol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1038\/s41598-017-02941-4","article-title":"RNA-sequencing Identifies Novel Pathways in sarcoidosis monocytes","volume":"7","author":"Talreja","year":"2017","journal-title":"Sci Rep"},{"key":"B188","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12016-013-8398-3","article-title":"Epigenetics in immune-mediated pulmonary diseases","volume":"45","author":"Liu","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"B190","doi-asserted-by":"publisher","first-page":"815953","DOI":"10.1155\/2012\/815953","article-title":"Alternatively activated macrophages in types 1 and 2 diabetes","volume":"2012","author":"Espinoza-Jimenez","year":"2012","journal-title":"Mediators Inflamm"},{"key":"B191","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/clim.2002.5265","article-title":"Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 1","volume":"105","author":"Zacher","year":"2002","journal-title":"Clin Immunol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"209","DOI":"10.7150\/ijbs.15659","article-title":"Increase in peripheral blood intermediate monocytes is associated with the development of recent-onset type 1 diabetes mellitus in children","volume":"13","author":"Ren","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B193","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/apm.12419","article-title":"Elevated levels of peripheral blood CD14(bright) CD16+ and CD14(dim) CD16+ monocytes may contribute to the development of retinopathy in patients with juvenile onset type 1 diabetes","volume":"123","author":"Ryba-Stanislawowska","year":"2015","journal-title":"APMIS"},{"key":"B194","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.2337\/dc12-2328","article-title":"Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes","volume":"36","author":"Brooks-Worrell","year":"2013","journal-title":"Diabetes Care"},{"key":"B195","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2249.1994.tb05517.x","article-title":"Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients","volume":"98","author":"Josefsen","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1034\/j.1399-5448.2003.00042.x","article-title":"Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset","volume":"4","author":"Litherland","year":"2003","journal-title":"Pediatr Diabetes"},{"key":"B197","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cyto.2012.03.010","article-title":"Expansion of CD14+CD16+ monocytes producing TNF-alpha in complication-free diabetes type 1 juvenile onset patients","volume":"60","author":"Mysliwska","year":"2012","journal-title":"Cytokine"},{"key":"B198","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1055\/s-0032-1331226","article-title":"Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes","volume":"45","author":"Harsunen","year":"2013","journal-title":"Horm Metab Res"},{"key":"B199","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1515\/jpem-2015-0340","article-title":"Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes","volume":"29","author":"Ismail","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B200","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.2337\/db13-1777","article-title":"A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes","volume":"63","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"key":"B201","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clim.2009.02.007","article-title":"DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced autoimmune diabetes","volume":"132","author":"Wolter","year":"2009","journal-title":"Clin Immunol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.2337\/db12-0099","article-title":"Dysregulated toll-like receptor-induced interleukin-1beta and interleukin-6 responses in subjects at risk for the development of type 1 diabetes","volume":"61","author":"Alkanani","year":"2012","journal-title":"Diabetes"},{"key":"B203","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1753425913502242","article-title":"Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade","volume":"20","author":"Hara","year":"2014","journal-title":"Innate Immun"},{"key":"B204","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.clim.2010.01.007","article-title":"Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetes","volume":"135","author":"Londono","year":"2010","journal-title":"Clin Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00109-013-1078-1","article-title":"Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes","volume":"92","author":"Hara","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B206","doi-asserted-by":"publisher","first-page":"E1418","DOI":"10.1210\/jc.2013-3864","article-title":"alpha1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1beta responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes","volume":"99","author":"Gottlieb","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B207","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.2337\/db08-1275","article-title":"Immunopathogenic interaction of environmental triggers and genetic susceptibility in diabetes: is epigenetics the missing link?","volume":"57","author":"Litherland","year":"2008","journal-title":"Diabetes"},{"key":"B208","doi-asserted-by":"publisher","first-page":"E3002","DOI":"10.1073\/pnas.1603712113","article-title":"Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT\/EDIC type 1 diabetes cohort","volume":"113","author":"Chen","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B209","doi-asserted-by":"publisher","first-page":"e1002300","DOI":"10.1371\/journal.pgen.1002300","article-title":"Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis","volume":"7","author":"Rakyan","year":"2011","journal-title":"PLoS Genet"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.2337\/db13-1251","article-title":"Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes","volume":"63","author":"Miao","year":"2014","journal-title":"Diabetes"},{"key":"B211","doi-asserted-by":"publisher","first-page":"16335","DOI":"10.1074\/jbc.M111.330373","article-title":"Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes","volume":"287","author":"Miao","year":"2012","journal-title":"J Biol Chem"},{"key":"B212","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2337\/db08-0645","article-title":"Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes","volume":"57","author":"Miao","year":"2008","journal-title":"Diabetes"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/db11-1549","article-title":"Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes","volume":"61","author":"Irvine","year":"2012","journal-title":"Diabetes"},{"key":"B214","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/ppe.12263","article-title":"Bacillus Calmette-Guerin (BCG) vaccination in infancy and risk of childhood diabetes","volume":"30","author":"Rousseau","year":"2016","journal-title":"Paediatr Perinat Epidemiol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.2337\/diacare.28.5.1204","article-title":"Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes","volume":"28","author":"Huppmann","year":"2005","journal-title":"Diabetes Care"},{"key":"B216","doi-asserted-by":"publisher","first-page":"e41756","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS One"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2941","article-title":"TNF, TNF inducers, and TNFR2 agonists: a new path to type 1 diabetes treatment","volume":"34","author":"Faustman","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"B218","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11926-017-0670-8","article-title":"Autoinflammatory diseases with PERIODIC FEVERS","volume":"19","author":"Sag","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"B219","first-page":"S121","article-title":"Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation","volume":"34","author":"Borghini","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00109-014-1150-5","article-title":"Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases","volume":"92","author":"Bachetti","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B221","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1002\/art.23133","article-title":"Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome","volume":"56","author":"Todd","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/rheumatology\/kel178","article-title":"Successful treatment using tacrolimus (FK506) in a patient with TNF receptor-associated periodic syndrome (TRAPS) complicated by monocytic fasciitis","volume":"45","author":"Ida","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1136\/annrheumdis-2012-201340","article-title":"Deficient production of IL-1 receptor antagonist and IL-6 coupled to oxidative stress in cryopyrin-associated periodic syndrome monocytes","volume":"71","author":"Carta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ni.3538","article-title":"NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations","volume":"17","author":"Mortimer","year":"2016","journal-title":"Nat Immunol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaci.2016.05.016","article-title":"DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes","volume":"139","author":"Vento-Tormo","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cyto.2014.06.012","article-title":"Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1beta, IL-1alpha and Th17-associated cytokines and decrease of Th1 and Th2 cytokines","volume":"69","author":"Ibrahim","year":"2014","journal-title":"Cytokine"},{"key":"B227","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0002-9343(91)90602-T","article-title":"Tumor necrosis factor in familial Mediterranean fever","volume":"90","author":"Schattner","year":"1991","journal-title":"Am J Med"},{"key":"B228","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000093089","article-title":"Impaired endotoxin tolerance induction in patients with familial Mediterranean fever","volume":"73","author":"Davtyan","year":"2006","journal-title":"Pathobiology"},{"key":"B229","first-page":"1983","article-title":"Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever","volume":"26","author":"Direskeneli","year":"1999","journal-title":"J Rheumatol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00296-006-0301-6","article-title":"Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever","volume":"27","author":"Simsek","year":"2007","journal-title":"Rheumatol Int"},{"key":"B231","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1574-695X.2008.00385.x","article-title":"Heightened endotoxin susceptibility of monocytes and neutrophils during familial Mediterranean fever","volume":"52","author":"Davtyan","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"B233","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","article-title":"Hyperimmunoglobulinaemia D and periodic fever: a new syndrome","volume":"1","author":"van der Meer","year":"1984","journal-title":"Lancet"},{"key":"B235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.157.1.400","article-title":"Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells","volume":"157","author":"Drenth","year":"1996","journal-title":"J Immunol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/rheumatology\/keu341","article-title":"TLR2\/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"54","author":"Stoffels","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-015-2923-0","article-title":"Macrophage activation syndrome in the course of monogenic autoinflammatory disorders","volume":"34","author":"Rigante","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B238","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00281-015-0492-6","article-title":"Hyper-IgD syndrome\/mevalonate kinase deficiency: what is new?","volume":"37","author":"Mulders-Manders","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/art.40146","article-title":"Open-label, phase II study to assess the efficacy and safety of canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome","volume":"69","author":"Arostegui","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B241","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.85.5.1620","article-title":"A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection","volume":"85","author":"van der Meer","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B242","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/eji.1830180728","article-title":"Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1","volume":"18","author":"Van\u2019t Wout","year":"1988","journal-title":"Eur J Immunol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(96)90403-1","article-title":"Chronic granulomatous disease in adults","volume":"347","author":"Liese","year":"1996","journal-title":"Lancet"},{"key":"B244","doi-asserted-by":"publisher","first-page":"252460","DOI":"10.1155\/2012\/252460","article-title":"Current concepts of hyperinflammation in chronic granulomatous disease","volume":"2012","author":"Rieber","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1073\/pnas.0914795107","article-title":"Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease","volume":"107","author":"van de Veerdonk","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2010-01-264218","article-title":"Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease","volume":"116","author":"Meissner","year":"2010","journal-title":"Blood"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jaci.2016.08.033","article-title":"Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease","volume":"139","author":"Gabrion","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B248","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1440-1711.2003.01190.x","article-title":"The inducibility of TNF-alpha production is different in the granulocytic and monocytic differentiated forms of wild type and CGD-mutant PLB-985 cells","volume":"81","author":"Selmeczy","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans","volume":"111","author":"de Luca","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.4161\/auto.28638","article-title":"Deficient autophagy unravels the ROS paradox in chronic granulomatous disease","volume":"10","author":"van de Veerdonk","year":"2014","journal-title":"Autophagy"},{"key":"B251","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/path.2298","article-title":"Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice","volume":"214","author":"Schappi","year":"2008","journal-title":"J Pathol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/path.4061","article-title":"Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells","volume":"228","author":"Deffert","year":"2012","journal-title":"J Pathol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2008.06.005","article-title":"ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease","volume":"129","author":"Brown","year":"2008","journal-title":"Clin Immunol"},{"key":"B254","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2009-07-233734","article-title":"Tryptophan\/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"key":"B255","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/jb\/mvj072","article-title":"The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines","volume":"139","author":"Fujigaki","year":"2006","journal-title":"J Biochem"},{"key":"B256","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jlb.53.6.673","article-title":"Chemotactic peptide-induced cytoplasmic pH changes in incubated human monocytes","volume":"53","author":"Bernardo","year":"1993","journal-title":"J Leukoc Biol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.33325","article-title":"A rare polymorphism in the gene for toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators","volume":"64","author":"Broen","year":"2012","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:33:23Z","timestamp":1751394803000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":257,"alternative-id":["10.3389\/fimmu.2018.00298"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00298","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"article-number":"298"}}